Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174847 | SCV000226226 | pathogenic | not provided | 2015-02-02 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001199499 | SCV001162570 | pathogenic | Retinitis pigmentosa | 2020-01-09 | criteria provided, single submitter | research | |
Ce |
RCV000174847 | SCV001245887 | pathogenic | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376192 | SCV001573244 | pathogenic | Retinitis pigmentosa 43 | 2021-04-08 | criteria provided, single submitter | research | The PDE6A c.1926+1G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM1. Based on this evidence we have classified this variant as Pathogenic. |
Labcorp Genetics |
RCV000174847 | SCV002969607 | pathogenic | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change affects a donor splice site in intron 15 of the PDE6A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PDE6A are known to be pathogenic (PMID: 7493036, 22128245, 23847139). This variant is present in population databases (rs794727139, gnomAD 0.0009%). Disruption of this splice site has been observed in individuals with retinitis pigmentosa (PMID: 33057649). ClinVar contains an entry for this variant (Variation ID: 194473). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. |
Institute of Human Genetics, |
RCV004816264 | SCV005070026 | pathogenic | Retinal dystrophy | 2012-01-01 | criteria provided, single submitter | clinical testing |